Quinolones Global Market Report 2024

Description

“Quinolones Global Market Report 2024 ” from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on quinolones market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

Gain a truly global perspective with the most comprehensive report available on this market covering 50+ geographies.
Understand how the market has been affected by the COVID-19 and how it is responding as the impact of the virus abates.
Assess the Russia - Ukraine war's impact on agriculture, energy and mineral commodity supply and its direct and indirect impact on the market.
Measure the impact of high global inflation on market growth.
Create regional and country strategies on the basis of local data and analysis.
Identify growth segments for investment.
Outperform competitors using forecast data and the drivers and trends shaping the market.
Understand customers based on the latest market shares.
Benchmark performance against key competitors.
Suitable for supporting your internal and external presentations with reliable high quality data and analysis
Report will be updated with the latest data and delivered to you within 3-5 working days of order along with an Excel data sheet for easy data extraction and analysis.
All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for quinolones? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? “The quinolones market global report ” from The Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

Scope

Markets Covered:

1) By Type: Norfloxacin; Ofloxacin; Ciprofloxacin; Gemifloxacin; Other Types
2) By Pathogen Type: Gram-Positive Pathogen; Gram-Negative Pathogen
3) By Application: Hospital Pharmacies; Retail Pharmacies; Online Pharmacies
Companies Mentioned: Bayer AG; Novartis AG; Sanofi SA; Johnson & Johnson Services Inc.; Merck & Co. Inc.
Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery format: PDF, Word and Excel Data Dashboard.

Executive Summary

Quinolones are a class of bactericidal antibiotics that exhibit the capability to directly kill bacterial cells, targeting both gram-positive and gram-negative bacteria. They are employed in the treatment of various infectious diseases caused by bacteria.

The primary types of quinolones include norfloxacin, ofloxacin, ciprofloxacin, gemifloxacin, and others. Norfloxacin, specifically a fluoroquinolone, is utilized for the treatment of diverse bacterial infections. Its applications extend to addressing conditions such as conjunctivitis and urinary tract infections, targeting both gram-positive and gram-negative pathogens. Quinolones are distributed through various channels, including hospital pharmacies, retail pharmacies, and online pharmacies.

The quinolones market research report is one of a series of new reports from The Business Research Company that provides, quinolones market statistics, including, quinolones industry global market size, regional shares, competitors with a quinolones market share, detailed, quinolones market segments, market trends and opportunities, and any further data you may need to thrive in the quinolones industry. This, quinolones market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The quinolones market size has grown steadily in recent years. It will grow from $48.31 billion in 2023 to $50.65 billion in 2024 at a compound annual growth rate (CAGR) of 4.9%. The growth observed in the historical period can be attributed to factors such as the demand for antibiotics and their usage, regulatory approvals, research and development activities, the competitive landscape within the pharmaceutical industry, and the expiration of patents.

The quinolones market size is expected to see steady growth in the next few years. It will grow to $61.51 billion in 2028 at a compound annual growth rate (CAGR) of 5.0%. The anticipated growth in the forecast period can be attributed to factors such as the emergence of new diseases, regulatory changes, global health policies, the increasing challenge of antibiotic resistance, and market expansion strategies. Key trends expected in the forecast period may include advancements or shifts in medical research, changes in healthcare policies, and evolving strategies to address antibiotic resistance.

The growth of the quinolones market is significantly attributed to the increasing incidence of infectious diseases. Infectious diseases, caused by microbes such as parasites, fungi, bacteria, and viruses, remain a global health challenge. Quinolones, widely employed in treating various bacterial infections such as tuberculosis and urinary tract infections, play a crucial role in addressing these health concerns. For example, data from 2022 provided by the Pan American Health Organization indicated that approximately 10.6 million people contracted tuberculosis (TB) in 2021, marking a 4.5% increase. Thus, the upsurge in infectious diseases is a driving force behind the growth of the quinolones market.

The anticipated rise in antimicrobial resistance contributes to the continued growth of the quinolones market. Antimicrobial resistance (AMR), the ability of microorganisms to resist the effects of antimicrobial drugs, poses a significant threat to public health. Quinolones, with their broad spectrum of activity and effectiveness against various bacteria, become a preferred choice in cases of limited options. Notably, in November 2022, the United Kingdom Health Security Agency reported a 2.2% increase in the predicted total number of severe antibiotic-resistant infections in England in 2021. This highlights the growing danger of antimicrobial resistance, which is propelling the demand for quinolones.

A prominent trend in the quinolones market is the emphasis on product innovation by major companies to sustain their market positions. For instance, in January 2023, Viatris, a US-based pharmaceutical company's South Korean branch introduced Dovprela, a novel treatment for drug-resistant tuberculosis. Dovprela, a three-drug regimen comprising bedaquiline, pretomanid, and linezolid (BPaL), offers a more rapid anti-tuberculosis effect, reducing the treatment period from 18-20 months to 5-6 months. This innovation addresses the pressing need for effective and efficient tuberculosis treatments.

Innovative products, such as fluoroquinolone antibiotic eye drops, are being introduced to drive revenues in the quinolones market. Fluoroquinolone antibiotic eye drops, a class of antibiotics targeting bacterial eye infections, contribute to ophthalmic health. For instance, Harrow Health Inc., a US-based pharmaceutical company, launched Vigamox in July 2023. This sterile ophthalmic solution, delivered in a 3-milliliter bottle, is indicated for the prevention of eye infections before and after surgery. Such innovative products cater to diverse medical needs and contribute to the market's growth.

In June 2023, Bausch + Lomb Incorporated, a US-based eye health company, acquired Novartis International AG for an undisclosed amount. Through this acquisition, Bausch + Lomb aims to restructure its pharmaceutical division, enhancing its scale and positioning it at the forefront of addressing ocular surface disorders. The acquisition diversifies Bausch + Lomb's product portfolio, introducing new opportunities such as libvatrep and AcuStream technology. Libvatrep is an experimental compound studied for treating chronic ocular surface pain, while AcuStream technology is an experimental device designed for accurate dosing and delivery of certain topical ophthalmic medications. Novartis International AG, based in Switzerland, is a pharmaceutical company with a global presence.

Major companies operating in the quinolones market report are Bayer AG, Novartis AG, Sanofi SA, Johnson & Johnson Services Inc., Merck & Co. Inc., LG Life Sciences, Allergan Inc., Pfizer Inc., Viatris Inc., Lupin Limited, Hikma Pharmaceuticals plc, Zydus Group, Bausch Health Companies Inc., KYORIN Holdings Inc., MerLion Pharmaceuticals GmbH, Teva Pharmaceutical Industries Ltd., GSK plc, AbbVie Inc., Zee Laboratories, Cipla Ltd., Bhavishya Pharmaceuticals, Geo Pharma Pvt. Ltd., Finecure Pharmaceuticals, Novus, AstraZeneca plc, Sun Pharmaceutical Industries Ltd., Dr. Reddy's Laboratories Ltd., Cadila Healthcare Ltd., Glenmark Pharmaceuticals Ltd., Alkem Laboratories Ltd., Torrent Pharmaceuticals Ltd., Macleods Pharmaceuticals Ltd., Alembic Pharmaceuticals Ltd., Hetero Drugs Ltd., Mylan N.V., Wockhardt Ltd

North America was the largest region in the quinolones market in 2023. The regions covered in the quinolones market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

The countries covered in the quinolones market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The quinolones market consists of sales of bedaquiline. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Product Code: r11281

1. Executive Summary

2. Quinolones Market Characteristics

3. Quinolones Market Trends And Strategies

4. Quinolones Market - Macro Economic Scenario

4.1. Impact Of High Inflation On the Market
4.2. Ukraine-Russia War Impact On the Market
4.3. COVID-19 Impact On the Market

5. Global Quinolones Market Size and Growth

5.1. Global Quinolones Market Drivers and Restraints
- 5.1.1. Drivers Of The Market
- 5.1.2. Restraints Of The Market
5.2. Global Quinolones Historic Market Size and Growth, 2018 - 2023, Value ($ Billion)
5.3. Global Quinolones Forecast Market Size and Growth, 2023 - 2028, 2033F, Value ($ Billion)

6. Quinolones Market Segmentation

6.1. Global Quinolones Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Norfloxacin
Ofloxacin
Ciprofloxacin
Gemifloxacin
Other Types
6.2. Global Quinolones Market, Segmentation By Pathogen Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Gram-Positive Pathogen
Gram-Negative Pathogen
6.3. Global Quinolones Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies

7. Quinolones Market Regional And Country Analysis

7.1. Global Quinolones Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
7.2. Global Quinolones Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

8. Asia-Pacific Quinolones Market

8.1. Asia-Pacific Quinolones Market Overview
Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
8.2. Asia-Pacific Quinolones Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
8.3. Asia-Pacific Quinolones Market, Segmentation By Pathogen Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
8.4. Asia-Pacific Quinolones Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

9. China Quinolones Market

9.1. China Quinolones Market Overview
9.2. China Quinolones Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
9.3. China Quinolones Market, Segmentation By Pathogen Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
9.4. China Quinolones Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion

10. India Quinolones Market

10.1. India Quinolones Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
10.2. India Quinolones Market, Segmentation By Pathogen Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
10.3. India Quinolones Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

11. Japan Quinolones Market

11.1. Japan Quinolones Market Overview
11.2. Japan Quinolones Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
11.3. Japan Quinolones Market, Segmentation By Pathogen Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
11.4. Japan Quinolones Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

12. Australia Quinolones Market

12.1. Australia Quinolones Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
12.2. Australia Quinolones Market, Segmentation By Pathogen Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
12.3. Australia Quinolones Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

13. Indonesia Quinolones Market

13.1. Indonesia Quinolones Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
13.2. Indonesia Quinolones Market, Segmentation By Pathogen Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
13.3. Indonesia Quinolones Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

14. South Korea Quinolones Market

14.1. South Korea Quinolones Market Overview
14.2. South Korea Quinolones Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
14.3. South Korea Quinolones Market, Segmentation By Pathogen Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
14.4. South Korea Quinolones Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

15. Western Europe Quinolones Market

15.1. Western Europe Quinolones Market Overview
15.2. Western Europe Quinolones Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
15.3. Western Europe Quinolones Market, Segmentation By Pathogen Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
15.4. Western Europe Quinolones Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

16. UK Quinolones Market

16.1. UK Quinolones Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
16.2. UK Quinolones Market, Segmentation By Pathogen Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
16.3. UK Quinolones Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

17. Germany Quinolones Market

17.1. Germany Quinolones Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
17.2. Germany Quinolones Market, Segmentation By Pathogen Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
17.3. Germany Quinolones Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

18. France Quinolones Market

18.1. France Quinolones Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
18.2. France Quinolones Market, Segmentation By Pathogen Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
18.3. France Quinolones Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

19. Italy Quinolones Market

19.1. Italy Quinolones Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
19.2. Italy Quinolones Market, Segmentation By Pathogen Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
19.3. Italy Quinolones Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

20. Spain Quinolones Market

20.1. Spain Quinolones Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
20.2. Spain Quinolones Market, Segmentation By Pathogen Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
20.3. Spain Quinolones Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

21. Eastern Europe Quinolones Market

21.1. Eastern Europe Quinolones Market Overview
21.2. Eastern Europe Quinolones Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
21.3. Eastern Europe Quinolones Market, Segmentation By Pathogen Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
21.4. Eastern Europe Quinolones Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

22. Russia Quinolones Market

22.1. Russia Quinolones Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
22.2. Russia Quinolones Market, Segmentation By Pathogen Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
22.3. Russia Quinolones Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

23. North America Quinolones Market

23.1. North America Quinolones Market Overview
23.2. North America Quinolones Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
23.3. North America Quinolones Market, Segmentation By Pathogen Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
23.4. North America Quinolones Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

24. USA Quinolones Market

24.1. USA Quinolones Market Overview
24.2. USA Quinolones Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
24.3. USA Quinolones Market, Segmentation By Pathogen Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
24.4. USA Quinolones Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

25. Canada Quinolones Market

25.1. Canada Quinolones Market Overview
25.2. Canada Quinolones Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
25.3. Canada Quinolones Market, Segmentation By Pathogen Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
25.4. Canada Quinolones Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

26. South America Quinolones Market

26.1. South America Quinolones Market Overview
26.2. South America Quinolones Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
26.3. South America Quinolones Market, Segmentation By Pathogen Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
26.4. South America Quinolones Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

27. Brazil Quinolones Market

27.1. Brazil Quinolones Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
27.2. Brazil Quinolones Market, Segmentation By Pathogen Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
27.3. Brazil Quinolones Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

28. Middle East Quinolones Market

28.1. Middle East Quinolones Market Overview
28.2. Middle East Quinolones Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
28.3. Middle East Quinolones Market, Segmentation By Pathogen Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
28.4. Middle East Quinolones Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

29. Africa Quinolones Market

29.1. Africa Quinolones Market Overview
29.2. Africa Quinolones Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
29.3. Africa Quinolones Market, Segmentation By Pathogen Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
29.4. Africa Quinolones Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

30. Quinolones Market Competitive Landscape And Company Profiles

30.1. Quinolones Market Competitive Landscape
30.2. Quinolones Market Company Profiles
- 30.2.1. Bayer AG
  - 30.2.1.1. Overview
  - 30.2.1.2. Products and Services
  - 30.2.1.3. Strategy
  - 30.2.1.4. Financial Performance
- 30.2.2. Novartis AG
  - 30.2.2.1. Overview
  - 30.2.2.2. Products and Services
  - 30.2.2.3. Strategy
  - 30.2.2.4. Financial Performance
- 30.2.3. Sanofi SA
  - 30.2.3.1. Overview
  - 30.2.3.2. Products and Services
  - 30.2.3.3. Strategy
  - 30.2.3.4. Financial Performance
- 30.2.4. Johnson & Johnson Services Inc.
  - 30.2.4.1. Overview
  - 30.2.4.2. Products and Services
  - 30.2.4.3. Strategy
  - 30.2.4.4. Financial Performance
- 30.2.5. Merck & Co. Inc.
  - 30.2.5.1. Overview
  - 30.2.5.2. Products and Services
  - 30.2.5.3. Strategy
  - 30.2.5.4. Financial Performance

31. Global Quinolones Market Competitive Benchmarking

32. Global Quinolones Market Competitive Dashboard

33. Key Mergers And Acquisitions In The Quinolones Market

34. Quinolones Market Future Outlook and Potential Analysis

34.1 Quinolones Market In 2028 - Countries Offering Most New Opportunities
34.2 Quinolones Market In 2028 - Segments Offering Most New Opportunities
34.3 Quinolones Market In 2028 - Growth Strategies
- 34.3.1 Market Trend Based Strategies
- 34.3.2 Competitor Strategies

35. Appendix

35.1. Abbreviations
35.2. Currencies
35.3. Historic And Forecast Inflation Rates
35.4. Research Inquiries
35.5. The Business Research Company
35.6. Copyright And Disclaimer